Depression and incidence of frailty in older people from six Latin American countries by Prina, Matthew et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.jagp.2019.04.008
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Prina, M., Stubbs, B., Veronese, N., Guerra, M., Kralj, C., Llibre Rodriguez, J., ... Wu, Y-T. (2019). Depression
and incidence of frailty in older people from six Latin American countries. American Journal of Geriatric
Psychiatry, 27(10), 1072-1079. https://doi.org/10.1016/j.jagp.2019.04.008
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 11. Jul. 2020
1 
 
Word count: 2657 
Depression and incidence of frailty in older people from six Latin American countries 
 
Authors 
A. Matthew Prina, PhD1,2, Brendon Stubbs, PhD3,4, Nicola Veronese, PhD5,6, Mariella Guerra, 
PhD7, Carolina Kralj, MD4, Juan J Llibre Rodriguez, PhD8, Martin Prince, MD2, Yu-Tzu Wu, 
PhD1 
 
Affiliations 
1. King’s College London, Social Epidemiology Research Group, Health Service and 
Population Research, Institute of Psychiatry, Psychology & Neuroscience, London, UK 
2. King’s College London, Global Health Institute, London, UK 
3. Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, 
London, UK  
4. South London and Maudsley NHS Foundation Trust, London, UK 
5. National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy 
6. Ambulatory of Nutrition, IRCCS “S. de Bellis” National Institute of Gastroenterology – 
Research Hospital, Castellana Grotte, Bari, Italy 
7. Institute of Memory, Depression and Disease Risk, Avda Constructores 1230, Lima 12, Peru  
2 
 
8. Facultad de Medicina Finlay-Albarran, Medical University of Havana, Havana, Cuba 
 
Corresponding author 
Yu-Tzu Wu 
King’s College London, Social Epidemiology Research Group, Health Service and Population 
Research, Institute of Psychiatry, Psychology & Neuroscience 
De Crespigny Park, London SE5 8AF, UK 
Email: yu-tzu.wu@kcl.ac.uk  
Telephone: +44 (0) 20 7848 5074 
 
Conflict of interests 
No disclosures to report. 
 
Previous presentation 
None 
 
 
 
 
3 
 
Acknowledgements 
This work was supported by grant from the Welcome Trust Health Consequences of 
Population Change Programme (GR066133—Prevalence phase in Cuba and Brazil; 
GR08002- Incidence phase in Peru, Mexico, Argentina, Cuba, Dominican Republic, 
Venezuela, and China), WHO (India, Dominican Republic, and China), the US Alzheimer’s 
Association (IIRG–04–1286—Peru, Mexico and Argentina), and FONACIT/ CDCH/ UCV 
(Venezuela). Matthew Prina was supported by the MRC (grant number: MR/K021907/1). The 
funding institutions were not involved in the study design, collection, analysis and 
interpretation of data, the writing of the paper nor had any involvement in the decision to 
submit the paper for publication. BS is supported by the Health Education England and the 
National Institute for Health Research HEE/NIHR ICA Programme Clinical Lectureship 
(ICA-CL-2018-03-001). The views expressed in this publication are those of the authors) and 
not necessarily those of the NHS, the National Institute for Health Research or the 
Department of Health and Social Care. 
 
Keywords 
Depression; Older age; Epidemiology; Frailty; Low- and middle-income countries 
 
 
4 
 
Abstract 
 
Objectives 
Frailty and depression are highly comorbid conditions but the casual direction is unclear and 
has not been explored in low- and middle-income countries. The aim of this study is to 
investigate the potential impact of depression on incident frailty in older people living in Latin 
America.  
 
Methods 
This study was based on a population-based cohort of 12844 people aged 65 or above from 
six Latin American countries (Cuba, Dominican Republic, Mexico, Venezuela, Puerto Rico 
and Peru), part of the 10/66 cohort study. Two types of frailty measures were used: a modified 
Fried frailty phenotype and a multi-dimensional frailty criteria, which included measures from 
cognition, sensory, nutrition and physical dimensions. Depression was assessed using 
EURO-D and ICD-10 criteria. A competing risk model was used to examine the associations 
between baseline depression and incidence of frailty in the 3-5 years of follow up accounting 
for sociodemographic and health factors and the competing event of frailty-free death.  
 
Results 
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Depression was associated with a 59% increased hazard of developing frailty using the 
modified Fried phenotype (subdistribution hazard ratio (SHR): 1.59; 95%CI: 1.40, 1.80) and 
19% for multi-dimensional frailty (SHR: 1.19; 95%CI: 1.06, 1.33) after adjusting for 
sociodemographic factors, physical impairments and dementia. The associations between 
depression and the multi-dimensional frailty criteria were homogenous across all the sites 
(Higgins I2=0%).  
 
Conclusions 
Depression may play a key role in the development of frailty. Pathways addressing the 
association between physical and mental health in older people need to be further investigated 
in future research. 
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INTRODUCTION 
Frailty is an age-related biological syndrome resulting in decreased physiological reserve and 
increased susceptibility to stressor during the ageing process [1,2] and ultimately in increased 
disability and mortality [3,4]. A meta-analysis estimated the prevalence of frailty to be 11% in 
community-dwelling older people but range was wide across studies (4-59%) [5]. A 
multicentre cohort study in five Latin American cities reported relatively high estimates in 
both men (21-35%) and women (30-48%) [6].  
 
Similar to frailty, depression is also a highly prevalent condition among older adults and has 
been linked to an increased risk of developing frailty in later life [7]. Although recent reviews 
have suggested bi-directional associations between depression and frailty in later life [8-11], it 
is important to investigate how depression might lead to incident frailty particularly in low 
and middle income countries, where high prevalence of depression has been reported in some 
settings but access to health services is limited [12]. Given the large number of older people in 
low and middle income countries, population-based longitudinal studies are needed to 
quantify the potential impact of depression on the development of frailty. This may lead to the 
identification of high risk group of individuals who are likely to become frail, potentially 
leading to a reduction in burden associated with both depression and frailty.  
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Based on the pooled estimates of four longitudinal studies from the US and Germany, older 
people with depression had fourfold increased odds of incident frailty, yet the reported 
heterogeneity of this meta-analysis was high [8]. This might be related to variation in research 
methods such as different measures for depression and frailty. In addition to the classical 
Fried criteria which focuses on five clinical markers related to declines in physical 
functioning [13], the multi-dimensional nature of frailty has been widely recognised in recent 
years [14] and several assessment methods have been developed to incorporate different 
dimensions of physical and mental health indicators [2,13-16]. However, few studies have 
included different frailty definitions and examined their effects on the association between 
depression and frailty. If the association varied across different frailty definitions, this might 
clarify possible pathways between depression and frailty. 
 
Using a population-based cohort of older people living in six Latin American countries, the 
aim of this study is to investigate the potential association between depression and incident 
frailty in later life. Moreover, we explore whether the associations maintain when a different 
definition of frailty is considered. 
 
MATERIALS AND METHODS  
Sample 
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The 10/66 Dementia Research Group carried out surveys of older people aged 65 and over 
living in 11 catchment areas across eight low and middle income countries (China, Cuba, 
Dominican Republic, India, Mexico, Peru, Puerto Rico and Venezuela). One urban and one 
rural site were present in China, Mexico and Peru, whereas the other countries only included 
an urban site. The catchment areas boundaries were well defined, and areas with high-income 
earners were avoided. The baseline surveys took place between 2003 and 2005 for all sites, 
with the exception of Puerto Rico, where data were collected from 2007. A full follow-up, 
was carried out 3 to 5 years after the baseline and date of death of those deceased were also 
recorded. Informed consent was obtained from all participants and verbal consent was used 
when participants were illiterate. The study was approved by local ethical committees and by 
the King's College London research ethics committee. Full details of the protocol and the 
cohort are available elsewhere [17,18]. 
 
This study only focused on a subset of the full 10/66 dataset (N= 15901), using 12844 
participants from the six Latin American countries. The Indian sites were excluded due to 
incomplete follow up data. Compared to Latin American countries, the prevalence of 
depression was found to be markedly low in the Chinese sites [12] and there was lack of 
statistical power to investigate its association with incident frailty.  
 
9 
 
Measurement 
Two types of frailty definitions were used in this analysis. The original Fried frailty phenotype 
includes five indicators: exhaustion, weight loss, weak grip strength, slow walking speed and 
low energy expenditure. The 10/66 cohort study assessed only four of the five indicators and 
did not include measures of hand grip strength [19,20]. Self-reported measures of exhaustion, 
weight loss (>10 lbs in the last 3 months) and low energy expenditure (physically inactive) 
were included in the interviews. Walking speed was assessed using a time walking test (5 
metres at usual speed, turn and return to the starting point) and the slowest quintile by gender 
and height stratum in each catchment area was considered to have a slow walking speed. 
Participants were defined as frail if they had two or more of the four frailty indicators, as done 
in previous studies [19,20]. To align with the literature [2], a cut-off of three or four frailty 
indicators was also applied yet very few people were belonged to this category (Table S1).   
 
The multi-dimensional frailty approach was developed in the Alameda County study [21] and 
previously used by our group [19,20]. It includes 16 self-reported items that form four broad 
domains of functioning (cognitive, nutrition, physical and sensory). The cognitive functioning 
domain included attention difficulties and memory. The nutrition domain included 
unexplained weight loss of appetite. The physical functioning domain included items 
measuring balance loss, dizziness, weakness in limbs. Finally, the sensory functioning domain 
10 
 
included hearing and vision difficulties. If difficulties in two or more domains were present, 
participants were considered frail. 
 
Since ICD-10 criteria were not specifically developed for older adults and might under-detect 
depression in later life, depression in this study was determined using both ICD-10 criteria, 
which was generated using specific GMS algorithms [12,22], and the EURO-D scale [23,24]. 
The EURO-D scale, which was developed to compare symptoms of late-life depression across 
11 European countries, has 12 items including depressed mood, pessimism, wishing death, 
guilt, sleep, interest, irritability, appetite, fatigue, concentration, enjoyment and tearfulness. 
Each item has a score of 0 (symptom not present) or 1 (symptom present), with a total score 
range between 0 and 12. Participants who met the ICD-10 depression criteria or had a 
EURO-D score of 4 or 5 were considered to have depression. Procedures to select the optimal 
cut-off of 4 or 5 on the EURO-D scale have been reported in the EURO-D validation papers, 
showing high sensitivity and specificity to a diagnosis of clinical depression in LMICs 
[23,24].  
 
Sociodemographic characteristics including age, gender and education (none/did not complete 
primary, completed primary, secondary, tertiary) were collected in the interviews. The 
measure for limiting physical impairments was based on 12 items of common physical 
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impairments [25], including arthritis/rheumatism, eyesight problems, hearing difficulty or 
deafness, persistent cough, breathlessness/asthma, high blood pressure, heart trouble/angina, 
stomach problems, intestine problems, faints/blackouts, skin disorders and paralysis/weakness 
or loss of one leg or an arm. Impairments were rated as present if they interfered with 
activities ‘a little’ or ‘a lot’, as opposed to ‘not at all’. The total number was then categorised 
into three groups: none, one or two, three or more. Dementia was assessed using the 10/66 
dementia diagnosis adjusted for education, which has been widely used in previous papers 
from the 10/66 Dementia Research Group, showing strong psychometric properties. Further 
information on this measure is available elsewhere [26]. 
 
Statistical analysis 
Before regression modelling, we reported the percentage of incident frailty by baseline 
depression status excluding those participants with frailty, either the modified Fried 
phenotype (N=2375) or multi-dimensional frailty (N=3886) at baseline. Since mortality was 
considered to be a competing outcome to frailty in later life, a competing risk model was used 
to investigate the associations between depression and incidence of frailty. Sub-hazard ratio 
estimates have similar interpretation to hazard ratios but also account for a competing event 
(frailty-free mortality). The proportional sub-hazard assumption was assessed generating time 
dependent covariates, by adding interactions of the predictors and a function of survival time 
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in the assessed model. Two types of frailty outcomes, the modified Fried phenotype and 
multi-dimensional frailty, were modelled separately. Adjusted models included 
sociodemographic factors (age, gender and education), number of limiting physical 
impairment and dementia, which is related to depression and incident frailty. The unadjusted 
and adjusted models were conducted for each country and pooled estimates of all six 
countries were generated using a fixed effect meta-analysis. Higgins I2, an indicator for the 
level of heterogeneity [27], was used to assess variation in effect sizes across the six 
countries. 
 
Inverse probability weighting was used to examine the potential impact of participants lost to 
follow up (N=1369; 13.1%) on the results. Weights were generated using all variables in the 
fully adjusted model and country and were applied to all competing risk models. Since the 
weighted estimates were similar to the unweighted ones, the results of complete case analysis 
are reported here. A sensitivity analysis was carried out to exclude people with dementia at 
baseline and examine whether the associations were different in the participants without 
dementia. All analyses were conducted using Stata 15.1. 
 
RESULTS 
Descriptive information on the baseline study population is provided in Table 1. Among the 
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12844 participants, the mean age was 74.7 (SD=7.2) and 64.5% were women. Nearly 40% 
had none or some education but did not complete primary school. The proportion of people 
with dementia was 10% and 17.8% had 3 or more limiting physical impairment. For frailty, 
18.5% of participants had modified Fried phenotype (two or more characteristics) and 30.3% 
had multi-dimensional frailty. More detailed information on the numbers of Fried frailty 
characteristics is reported in Supporting Information Table S1. Approximately 12% (N=1546) 
of participants were identified as having frailty using both definitions. The proportion of 
people with depression at baseline was 26.9% with a range between 16.5% in Puerto Rico and 
37.9% in Dominican Republic. 
 
Table 2 reports the numbers and percentage of frailty at follow up by depression status. 
Participants who had frailty at baseline were excluded. The percentages of both the modified 
Fried frailty phenotype and multi-dimensional frailty were higher in participants with 
depression at baseline than those without the condition across all countries. 
 
The results of competing risk modelling are reported in Table 3. Depression was associated 
with an increased hazard of incident frailty. For the modified Fried phenotype defined by two 
or more characteristics, the unadjusted pooled estimate was 1.87 (95% CI: 1.66, 2.10; 
Z-test=10.56; p-value<0.001) which was reduced to 1.59 (95% CI: 1.40, 1.80; Z-test=7.29; 
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p-value<0.001) after taking into account sociodemographic factors, physical impairment and 
dementia. The association was also found in the modified Fried phenotype defined by three or 
four characteristics (1.71; 95% CI: 1.24, 2.38; Z-test=3.24; p-value=0.001). For 
multi-dimensional frailty, the unadjusted effect size was 1.29 (95% CI: 1.16, 1.43; Z-test=4.67; 
p-value<0.001) and became 1.19 (95% CI: 1.06, 1.33; Z-test=3.02; p-value=0.002) after 
adjustment. Variations in hazard ratios across countries were also smaller when using the 
multi-dimensional frailty (I2=0.0) compared to the modified Fried phenotype (I2=63.5). All 
countries apart from Cuba showed a 20-30% higher hazard of incident multi-dimensional 
frailty in those who had depression at baseline. 
 
The results of sensitivity analysis showed that the associations between depression and frailty 
were robust when excluding people with dementia at baseline (Supporting Information Table 
S2). The effect sizes were generally similar to the main analysis. 
 
DISCUSSION 
Main findings 
This study investigated the potential impact of depression on incident frailty in older people 
from six Latin American countries and considered both modified Fried phenotype and 
multi-dimensional frailty. The results suggest that older people who had depression were more 
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likely to develop frailty compared to those without depression. Depression, a highly prevalent 
condition in later life, was associated with a 60% increased hazard of modified Fried 
phenotype frailty and 20% for multi-dimensional frailty after adjusting for sociodemographic 
factors, physical impairments and dementia and taking into account the competing outcome of 
mortality. This means that up to one-thirds of frailty could be attributed to depression in later 
life. 
 
Strengths and limitations 
Based on a population-based cohort study, this study included a large number of older people 
in six Latin American countries. Complete information on physical and mental health 
conditions were collected through standardised and structured interviews. The analysis 
included two types of frailty measures and used competing risk modelling to account for high 
mortality in later life.  
 
This study had some potential limitations. Although the 10/66 sample was selected to be as 
representative as possible of the general population, it is based on catchment areas which are 
not nationally representative. This might affect generalisability of the results but the strong 
association between depression and frailty was clear across older people in different settings. 
A modified version of Fried phenotype frailty was used here [19,20] and the results might not 
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be comparable to existing studies using the full Fried criteria. However, lack of grip strength 
information might not affect the results. Previous studies have reported that the association 
between grip strength and adverse health conditions was attenuated when adjusting for other 
frailty indicators and confounding factors [28,29]. Although the multi-dimensional criteria 
was used to incorporate a wide range of indicators related to frailty, some domains such as 
cognition and nutrition could be sensitive to cultural and environmental factors. Due to 
limited statistical power, the analysis did not test variation across countries but 95% 
confidence intervals largely overlapped. Some factors such as biomarkers for inflammation 
and dopamine could be mediators in the association between depression and frailty [8,11] but 
were not investigated in this study due to lack of relevant measures in the 10/66 surveys.  
 
Interpretation of results 
This study suggests a negative impact of depression on incident frailty in later life and 
provides additional evidence from low and middle income countries. The negative 
relationship corresponds to a recent meta-analysis, which summarised eight cross-sectional 
studies and four longitudinal studies mainly based on older people living in high income 
countries [8]. Compared to the pooled estimates reported in the meta-analysis, the effect sizes 
found in this study were much smaller for both frailty definitions. Although a negative 
relationship between depression and frailty in later life has been consistently reported in study 
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populations from different countries, it is noteworthy that the strength of associations could be 
related to variations in study designs and measurement methods.  
 
The effect sizes were found to be different when using the modified Fried frailty phenotype 
and multi-dimensional criteria. This may have been driven by two explanations: a) frailty 
measured using Fried criteria tries to capture a unidimensional latent trait summarised as a 
dichotomous syndrome. This definition has very strong theoretical and biological 
underpinnings, which may reflect an identifiable and shared bio-inflammatory pathway 
between depression and frailty [8,11]; For example, C-reactive protein and interleukin-6 have 
been shown to be elevated in both people with frailty and people with depression [30,31] b) 
one of the criteria of Fried frailty (exhaustion) is very common in people with depression [32]. 
We therefore expected to see a stronger relationship between depression and this definition of 
frailty, compared to multi-dimensional frailty.    
 
The results from this study suggest that depression in later life may increase the hazard of 
developing frailty. Depressive symptoms can cause changes in sleep, appetite, physical 
activity, reduction in help seeking behaviour and adherence to medical treatments [33-35]. 
These psychological and behaviour symptoms might lead to weakness, decreased energy and 
accelerate declines in physiological systems such as immune system [11,36,37].  
18 
 
 
Implications and future research directions 
Depression is a treatable condition and improving treatments for this common mental disorder 
in later life may be beneficial to reduction in disability and mortality [38] as well as frailty 
prevention. Underlying mechanisms between depression and frailty need to be further 
explored in order to inform potential interventions. To clarify the causal relationship, 
longitudinal studies need to have frequent follow up and robust measures for depression and 
frailty over a long time period. Future research may also consider the cumulative effect of 
depression through the lifecourse. For example, long-term depression has been related to 
brain inflammation [39]. Measurements for midlife depression may provide additional 
information to underpin potential pathways and clarify the role of inflammation in these two 
conditions. 
 
 
 
 
 
 
 
19 
 
REFERENCES 
1 British Geriatric Society. What is frailty? 
www.bgs.org.uk/frailty-explained/resources/campaigns/fit-for-frailty/frailty-what-is-it 
2014 
2 Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J 
Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56. 
3 Makizako H, Shimada H, Doi T, et al Impact of physical frailty on disability in 
community-dwelling older adults: a prospective cohort study. BMJ Open 2015;5:e008462. 
doi: 10.1136/bmjopen-2015-008462 
4 Kojima G, Iliffe S, Walters K. Frailty index as a predictor of mortality: a systematic 
review and meta-analysis. Age Ageing. 2018;47(2):193-200. doi: 10.1093/ageing/afx162. 
5 Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in 
community-dwelling older persons: a systematic review. J Am Geriatr Soc. 
2012;60(8):1487-92. doi: 10.1111/j.1532-5415.2012.04054.x. 
6 Alvarado BE, Zunzunegui MV, Béland F, Bamvita JM. Life course social and health 
conditions linked to frailty in Latin American older men and women. J Gerontol A Biol 
Sci Med Sci. 2008;63(12):1399-406. 
7 World Health Organisation. Mental health of older adults. Geneva: World Health 
Organisation, 2017. Available: 
20 
 
http://www.who.int/news-room/fact-sheets/detail/mental-health-of-older-adults 
8 Soysal P, Veronese N, Thompson T, et al. Relationship between depression and frailty in 
older adults: A systematic review and meta-analysis. Ageing Res Rev. 2017;36:78-87. doi: 
10.1016/j.arr.2017.03.005. 
9 Buigues C, Padilla-Sánchez C, Garrido JF, Navarro-Martínez R, Ruiz-Ros V, Cauli O. The 
relationship between depression and frailty syndrome: a systematic review. Aging Ment 
Health. 2015;19(9):762-72. doi: 10.1080/13607863.2014.967174. 
10 Vaughan L, Corbin AL, Goveas JS. Depression and frailty in later life: a systematic review. 
Clin Interv Aging. 2015;10:1947-58. doi: 10.2147/CIA.S69632. eCollection 2015. 
11 Brown PJ, Rutherford BR, Yaffe K, Tandler JM, Ray JL, Pott E, Chung S, Roose SP. The 
depression frail phenotype: the clinical manifestation of increased biological ageing. Am J 
Geriatr Psychiatry. 2016;24(11):1084-1094. 
12 Guerra M, Prina AM, Ferri CP, et al. A comparative cross-cultural study of the prevalence 
of late life depression in low and middle income countries. Journal of Affective Disorders. 
2016;190:362-368. doi:10.1016/j.jad.2015.09.004. 
13 Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A 
Biol Sci Med Sci. 2007;62(7):722-7. 
14 Rodríguez-Mañas L, Féart C, Mann G, et al. Searching for an operational definition of 
frailty: a Delphi method based consensus statement: the frailty operative 
21 
 
definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2012;68(1):62–
67.  
15 Romero-Ortuno R, Walsh CD, Lawlor BA, Kenny RA. A frailty instrument for primary 
care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). 
BMC Geriatr. 2010;10:57. doi: 10.1186/1471-2318-10-57. 
16 de Vries NM, Staal JB, van Ravensberg CD, Hobbelen JS, Olde Rikkert MG, Nijhuis-van 
der Sanden MW. Outcome instruments to measure frailty: a systematic review. Ageing 
Res Rev. 2011;10(1):104-14. doi: 10.1016/j.arr.2010.09.001. 
17 Prince M, Ferri CP, Acosta D, et al. The protocols for the 10/66 dementia research group 
population-based research programme. BMC Public Health 2007;7:165.  
18 Prina AM, Acosta D, Acostas I, et al. Cohort Profile: the 10/66 study. International Journal 
of Epidemiology. 2016. doi: 10.1093/ije/dyw056 
19 Llibre Rodriguez JJ, Prina AM, Acosta D, et al. The prevalence and correlates of frailty in 
urban and rural populations in Latin America, China, and India: a 10/66 population-based 
survey. J Am Med Dir Assoc. 2018;19(4):287-295.e4. doi: 10.1016/j.jamda.2017.09.026.  
20 Jotheeswaran AT, Bryce R, Prina M, et al. Frailty and the prediction of dependence and 
mortality in low- and middle-income countries: a 10/66 population-based cohort study. 
BMC Medicine. 2015;13:138. doi:10.1186/s12916-015-0378-4. 
21 Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty 
22 
 
over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 
1998;53(1):S9-16. 
22 Prina AM, Ferri CP, Guerra M, Brayne C, Prince M. Prevalence of anxiety and its 
correlates among older adults in Latin America, India and China: cross-cultural study. The 
British Journal of Psychiatry. 2011;199(6):485-491. doi:10.1192/bjp.bp.110.083915. 
23 Guerra M, Ferri C, Llibre J, Prina AM, Prince M. Psychometric properties of EURO-D, a 
geriatric depression scale: a cross-cultural validation study. BMC Psychiatry. 2015;15:12. 
24 Brailean A, Guerra M, Chua K-C, Prince M, Prina MA. A multiple indicators multiple 
causes model of late-life depression in Latin American countries. Journal of Affective 
Disorders. 2015;184:129-136. doi:10.1016/j.jad.2015.05.053. 
25 Duke University. Center for the Study of Aging and Human Development and Duke 
University. Older Americans Resources and Services Program Multidimensional 
functional assessment : the OARS methodology : a manual (2nd ed). Duke University, 
Center for the Study of Aging and Human Development, Durham, N.C, 1978. 
26 Prince M, Acosta D, Chiu H, Scazufca M, Varghese M, 10/66 Dementia Research Group. 
Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet. 
2003;361(9361):909-17. 
27 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in 
meta-analyses. BMJௗ: British Medical Journal. 2003;327(7414):557-560. 
23 
 
28 Boyd CM, Xue Q-L, Simpson CF, Guralnik JM, Fried LP. Frailty, hospitalization, and 
progression of disability in a cohort of disabled older women. American Journal of 
Medicine 2005;118(11):1225-1231. 
29 Syddall H, Cooper C, Martin F, Briggs R, Aihie SA. Is grip strength a useful single marker 
of frailty? Age & Ageing 2003;32(6):650-6. 
30 Soysal P, Stubbs B, Lucato P, et al. Inflammation and frailty in the elderly: A systematic 
review and meta-analysis. Ageing research reviews. 2016;31:1-8. 
31 Smith KJ, Au B, Ollis L, Schmitz N. The association between C-reactive protein, 
Interleukin-6 and depression among older adults in the community: A systematic review 
and meta-analysis. Experimental Gerontology 2018;102:109-132. 
32 Mezuk B, Lohman M, Dumenci L, Lapane KL. Are depression and frailty overlapping 
syndromes in mid- and late-life? A latent variable analysis. American Journal of Geriatric 
Psychiatry. 2013;21(6):560-569. doi:10.1016/j.jagp.2012.12.019. 
33 Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a 
clinical review. Eur Heart J. 2014;35(21):1365-72. doi: 10.1093/eurheartj/eht462. 
34 Henderson C, Evans-Lacko S, Thornicroft G. Mental Illness Stigma, Help Seeking, and 
Public Health Programs. American Journal of Public Health. 2013;103(5):777-780.  
35 DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance 
with medical treatment: meta-analysis of the effects of anxiety and depression on patient 
24 
 
adherence. Arch Intern Med. 2000;160(14):2101-7. 
36 Schuch FB, Vancampfort D, Firth J, et al. Physical activity and incident depression: a 
meta-analysis of prospective cohort studies. Am J Psychiatry. 2018;175(7):631-648. 
37 Rogers NT, Marshall A, Roberts CH, Demakakos P, Steptoe A, Scholes S. Physical 
activity and trajectories of frailty among older adults: evidence from the English 
Longitudinal Study of Ageing. PloS ONE. 2017;12(2):e0170878. 
38 Rodda J, Walker Z, Carter J. Depression in older adults. BMJ. 2011;343:d5219. doi: 
10.1136/bmj.d5219. 
39 Miller AH, Raison CL. The role of inflammation in depression: from evolutionary 
imperative to modern treatment target. Nature reviews Immunology. 2016;16(1):22-34. 
 
 
 
 
 
 
 
 
 
25 
 
Tables 
 
Table 1: Descriptive information on the study population at baseline 
 Cuba Dominican 
Republic 
Peru Venezuela Mexico Puerto 
Rico 
Total 
N 2937 2009 1933 1961 2002 2002 12844 
Age (Mean, SD) 75.1 
(7.0) 
75.3 
(7.5) 
74.8 
(7.4) 
72.5 
(6.9) 
74.3 
(6.7) 
76.3 
(7.4) 
74.7 
(7.2) 
Women (N, %) 1909 
(65.0) 
1325 
(66.0) 
1183 
(61.2) 
1249 
(63.7) 
1267 
(63.3) 
1347 
(67.3) 
8280 
(64.5) 
Education (N, %) 
None 75 
(2.6) 
392 
(19.7) 
121 
(6.3) 
155 
(8.1) 
554 
(27.7) 
72 
(3.6) 
1369 
(10.7) 
Some 651 
(22.2) 
1021 
(51.3) 
231 
(12.1) 
444 
(23.1) 
863 
(43.2) 
389 
(19.5) 
3599 
(28.2) 
Primary 977 
(33.4) 
370 
(18.6) 
727 
(37.9) 
964 
(50.2) 
351 
(17.6) 
415 
(20.8) 
3804 
(29.8) 
Secondary 728 
(24.9) 
135 
(6.8) 
517 
(27.0) 
266 
(13.8) 
124 
(6.2) 
713 
(35.7) 
2483 
(19.5) 
Tertiary 498 
(17.0) 
73 
(3.7) 
321 
(16.7) 
93 
(4.8) 
108 
(5.4) 
410 
(20.5) 
1503 
(11.8) 
Missing 8 18 16 39 2 3 86 
Dementia (N, %) 322 
(11.0) 
242 
(12.1) 
166 
(8.6) 
142 
(7.2) 
179 
(8.9) 
233 
(11.7) 
1284 
(10.0) 
 Missing 0 0 0 0 0 9 9 
Physical impairment (N, %) 
 None 1286 
(43.9) 
599 
(29.8) 
887 
(45.9) 
748 
(38.8) 
835 
(41.7) 
708 
(35.4) 
5063 
(39.6) 
 1-2 1353 
(46.2) 
945 
(47.1) 
780 
(40.4) 
693 
(35.9) 
824 
(41.2) 
865 
(43.2) 
5460 
(42.7) 
3+ 292 
(10.0) 
464 
(23.1) 
264 
(13.7) 
488 
(25.3) 
343 
(17.1) 
429 
(21.4) 
2280 
(17.8) 
Missing 6 1 2 32 0 0 41 
Modified Fried 
phenotype frailty 
(N, %) 
601 
(20.5) 
683 
(34.0) 
451 
(23.3) 
220 
(11.2) 
183 
(9.1) 
237 
(11.8) 
2375 
(18.5) 
Multi-dimensional 
frailty (N, %) 
976 
(33.2) 
942 
(46.9) 
524 
(27.1) 
405 
(20.7) 
592 
(29.6) 
447 
(22.3) 
3886 
(30.3) 
Depression (N, %) 683 
(23.3) 
761 
(37.9) 
537 
(27.8) 
574 
(29.3) 
574 
(28.7) 
330 
(16.5) 
3459 
(26.9) 
 
26 
 
Table 2: Depression status at baseline and frailty at follow up (depression symptomatology is 
defined as having either EURO-D or ICD-10 depression) 
  Modified Fried phenotype 
frailty (2-4 characteristics) 
at follow up:  
N (%) 
Multi-dimensional frailty 
at follow up:  
N (%) 
 Depression status No Yes No Yes 
Cuba No depression 1202 (87.7) 184 (13.3) 859 (71.1) 350 (29.0) 
 Symptoms 231 (80.2) 57 (19.8) 182 (67.2) 89 (32.8) 
Dominican Republic  No depression 454 (76.7) 138 (23.3) 326 (64.7) 178 (35.3) 
 Symptoms  138 (60.5) 90 (39.5) 96 (52.5) 87 (47.5) 
Peru No depression 681 (84.1) 129 (15.9) 645 (84.8) 116 (15.2) 
 Symptoms  166 (77.9) 47 (22.1) 174 (78.0) 49 (22.0) 
Venezuela No depression 804 (94.5) 47 0(5.5) 663 (85.0) 117 (15.0) 
 Symptoms 246 (86.9) 37 (13.1) 211 (83.7) 41 (16.3) 
Mexico No depression 787 (79.5) 203 (20.5) 523 (65.0) 282 (35.0) 
 Symptoms 233 (65.6) 122 (34.4) 143 (55.2) 116 (44.8) 
Puerto Rico No depression 821 (82.8) 171 (17.2) 624 (68.9) 282 (31.1) 
 Symptoms 87 (58.4) 62 (41.6) 98 (60.9) 63 (39.1) 
Across centres No depression 4749 (84.5) 872 (15.5) 3640 (73.3) 1325 (26.7) 
 Symptoms 1101 (72.6) 415 (27.4) 904 (67.0) 445 (33.0) 
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Table 3: Sub-hazard ratios for incident frailty in participants with depressive symptomatology (either EURO-D OR ICD-10 criteria) at baseline. 
 Modified Fried phenotype frailty 
(2-4 characteristics) 
Modified Fried phenotype frailty 
(3-4 characteristics) 
Multi-dimensional frailty 
 Model 1  
SHR (95% CI)* 
Model 2 
SHR (95% CI)* 
Model 3 
SHR (95% CI)* 
Model 1  
SHR (95% CI)* 
Model 2 
SHR (95% CI)* 
Model 3 
SHR (95% CI)* 
Model 1  
SHR (95% CI)* 
Model 2  
SHR (95% CI)* 
Model 3  
SHR (95% CI)* 
Cuba 1.41 (1.05, 1.90) 1.28 (0.94, 1.74) 1.24 (0.91, 1.69) 2.59 (1.20, 5.60) 2.24 (0.98, 5.12) 2.17 (0.93, 5.03) 1.00 (0.79, 1.25) 0.97 (0.77, 1.23) 0.99 (0.79, 1.26) 
DR 1.91 (1.47, 2.47) 1.70 (1.30, 2.23) 1.54 (1.15, 2.08) 2.95 (1.66, 5.23) 2.50 (1.39, 4.48) 1.92 (0.99, 3.71) 1.46 (1.14, 1.87) 1.34 (1.03, 1.73) 1.32 (1.00, 1.73) 
Peru 1.31 (0.95, 1.82) 1.31 (0.93, 1.84) 1.22 (0.86, 1.73) 0.57 (0.17, 1.93) 0.57 (0.16, 1.98) 0.34 (0.08, 1.44) 1.39 (1.00, 1.94) 1.38 (0.97, 1.96) 1.33 (0.93, 1.89) 
Venezuela 3.00 (1.96, 4.60) 2.93 (1.89, 4.52) 2.65 (1.67, 4.22) 2.96 (0.75, 11.21) 2.35 (0.61, 9.02) 2.00 (0.43, 9.21) 1.29 (0.90, 1.85) 1.26 (0.87, 1.85) 1.23 (0.83, 1.82) 
Mexico 1.72 (1.38, 2.15) 1.62 (1.29, 2.04) 1.52 (1.20, 1.93) 1.66 (0.90, 3.07) 1.59 (0.83, 3.08) 1.47 (0.79, 2.74) 1.36 (1.10, 1.69) 1.27 (1.02, 1.59) 1.23 (0.98, 1.54) 
Puerto Rico 2.78 (2.11, 3.67) 2.52 (1.90, 3.35) 2.18 (1.61, 2.95) 3.38 (1.81, 6.31) 2.94 (1.52, 5.68) 2.18 (1.11, 4.26) 1.36 (1.04, 1.76) 1.32 (1.01, 1.74) 1.21 (0.91, 1.61) 
Pooled 1.87 (1.66, 2.10) 1.74 (1.54, 1.96) 1.59 (1.40, 1.80) 2.36 (1.75, 3.18) 2.09 (1.53, 2.86) 1.71 (1.24, 2.38) 1.29 (1.16, 1.43) 1.23 (1.10, 1.37) 1.19 (1.06, 1.33) 
I2 76.3 73.5 63.3 41.2 20.2 17.0 20.3 2.5 0.0 
DR: Dominican Republic; SHR: sub-hazard ratio; 95% CI: 95% confidence interval; Model 1: unadjusted; Model 2: adjusted for age, gender and education level; Model 3: 
adjusted for age, gender, education level, number of physical impairments and dementia; *Z-test for coefficients estimated in competing risk models and pooled estimates in 
meta-analysis 
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Supporting Information 
 
Table S1: Numbers of Fried frailty characteristics across the six countries.  
 
Fried frailty 
Cuba Dominican 
Republic 
Peru Venezuela Mexico Puerto Rico Total 
0 530 (31.7) 198 (24.2) 421 (41.2) 725 (63.9) 451 (33.5) 408 (35.8) 2733 (38.3) 
1 903 (53.9) 394 (48.1) 426 (41.6) 325 (28.7) 569 (42.3) 500 (43.8) 3117 (43.7) 
2 213 (12.7) 182 (22.2) 154 (15.1) 75 0(6.6) 282 (21.0) 186 (16.3) 1092 (15.3) 
3 25 0(1.5) 44 0(5.4) 19 0(1.9) 8 0(0.7) 42 0(3.1) 43 0(3.8) 181 0(2.5) 
4 3 0(0.2) 2 0(0.2) 3 0(0.3) 1 0(0.1) 1 0(0.1) 4 0(0.4) 14 0(0.2) 
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Table S2: The relationship between depression and incident frailty in people without 
dementia. 
 Modified Fried phenotype frailty 
 
Multi-dimensional frailty 
 
 Model 1  
SHR  
(95% CI) 
Model 2 
SHR  
(95% CI) 
Model 3 
SHR  
(95% CI) 
Model 1  
SHR  
(95% CI) 
Model 2  
SHR  
(95% CI) 
Model 3  
SHR  
(95% CI) 
Cuba 1.56 
(1.11, 2.19) 
1.47 
(1.03, 2.09) 
1.43 
(1.00, 2.04) 
1.04 
(0.81, 1.34) 
1.13 
(0.87, 1.47) 
1.15 
(0.88, 1.50) 
Dominican 
Republic 
1.90 
(1.40, 2.57) 
1.73 
(1.25, 2.40) 
1.55 
(1.10, 2.20) 
1.48 
(1.12, 1.97) 
1.36 
(1.01, 1.83) 
1.29 
(0.95, 1.76) 
Peru 1.34 
(0.94, 1.92) 
1.32 
(0.92, 1.90) 
1.28 
(0.89, 1.85) 
1.38 
(0.96, 2.00) 
1.39 
(0.95, 2.04) 
1.31 
(0.88, 1.94) 
Venezuela 2.91 
(1.71, 4.94) 
3.04 
(1.68, 5.49) 
2.91 
(1.58, 5.38) 
1.16 
(0.69, 1.95) 
1.43 
(0.83, 2.45) 
1.33 
(0.77, 2.32) 
Mexico 1.99 
(1.54, 2.59) 
1.89 
(1.45, 2.47) 
1.75 
(1.23, 2.32) 
1.48 
(1.16, 1.89) 
1.44 
(1.11, 1.86) 
1.39 
(1.07, 1.79) 
Puerto Rico 2.82 
(2.07, 3.84) 
2.75 
(2.00, 3.78) 
2.33 
(1.66, 3.29) 
1.35 
(1.00, 1.82) 
1.26 
(0.92, 1.72) 
1.15 
(0.83, 1.59) 
Pooled 1.97 
(1.72, 2.25) 
1.87 
(1.63, 2.15) 
1.71 
(1.48, 1.98) 
1.32 
(1.17, 1.49) 
1.31 
(1.15, 1.49) 
1.26 
(1.11, 1.44) 
I2 62.9 63.5 48.6 4.8 0.0 0.0 
 
Competing risk model sub-hazard ratio (SHR) and 95% confidence interval (CI) 
Model 1: unadjusted 
Model 2: adjusted for age, gender and education level 
Model 3: adjusted for age, gender, education level and number of physical impairments 
 
 
 
 
 
 
